ClassID:

97044

C07K14/70557 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Integrin superfamily Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61

Recent Application in this class:
#1
20250042959
2025-02-06

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

#2
20230417764
2023-12-28

METHODS FOR TREATING DRUG RESISTANT CANCERS

#3
20220347113
2022-11-03

PEPTIDES AND METHODS OF TREATING SEPSIS, ATHEROSCLEROSIS, THROMBOSIS, STROKE, HEART ATTACK AND INFLAMMATION

#4
20220127329
2022-04-28

ALTERNATIVE INTRACELLULAR SIGNALLING DOMAIN OF A CHIMERIC ANTIGEN RECEPTOR

#5
20220119488
2022-04-21

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN ALPHA-V-BETA-3

#6
20210332093
2021-10-28

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

#7
20210107968
2021-04-15

Fusion protein, preparation method therefor and use thereof

#8
20210054026
2021-02-25

Inhibitors of β integrin-G protein α subunit binding interactions

#9
20200339681
2020-10-29

ANTIBODY INHIBITING ACTIVATED RAS IN CELL BY INTERNALIZING INTO CYTOSOL OF CELL, AND USE THEREOF

#10
20190352355
2019-11-21

Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis

#11
20190023740
2019-01-24

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#12
20180223376
2018-08-09

Compositions and methods for identifying anti cancer, anti-metastatic and anti-stress agents

#13
20180044403
2018-02-15

INTEGRIN-TARGETING PROTEIN AND METHODS OF USE THEREOF

#14
20170198023
2017-07-13

COMPOUNDS AND METHODS OF MODULATING ANGIOGENESIS

#15
20160289297
2016-10-06

Reversible platelet inhibition

#16
20160257711
2016-09-08

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#17
20140228295
2014-08-14

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#18
20130072433
2013-03-21

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#19
20120264815
2012-10-18

Reversible platelet inhibition

#20
20120020967
2012-01-26

VEGF antibodies comprising modular recognition domains

#21
20120020966
2012-01-26

Multispecific antibody targeting and multivalency through modular recognition domains

#22
20110117118
2011-05-19

Molecules, compositions, methods and kits for applications associated with flaviviruses

#23
20100210525
2010-08-19

Combined preparation of a thiazide diuretic and a loop diuretic

#24
20100173292
2010-07-08

GPIIIa gene

#25
20090227768
2009-09-10

Anti-Allergic Complex Molecules

#26
20090092622
2009-04-09

MOLECULES, COMPOSITIONS, METHODS AND KITS FOR APPLICATIONS ASSOCIATED WITH FLAVIVIRUSES

#27
20080175871
2008-07-24

ELICITING IMPROVED IMMUNE RESPONSES

#28
20080175840
2008-07-24

Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies

#29
20070021917
2007-01-25

3-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor

#30
20060100141
2006-05-11

Anti-allergic complex molecules

#31
20050130137
2005-06-16

Soluble recombinant αβadhesion receptor

#32
20050114109
2005-05-26

STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND

#33
20050084491
2005-04-21

Peptides antagonistic to an anti-angiogenic antibody and uses therefor

#34
20050002936
2005-01-06

Methods of treating arthritis and diabetic retinopathy with αβ-specific antibodies